List of Figures

Figure 2-1: Global - Prostate Cancer Therapeutics Market (Million US$), 2010 - 2014
Figure 2-2: Global - Forecast for Prostate Cancer Therapeutics Market (Million US$), 2015 - 2020
Figure 3-1: Global - Prostate Cancer Incidence (Number), 2007 - 2014
Figure 3-2: Global - Forecast for Prostate Cancer Incidence (Number), 2015 - 2020
Figure 5-1: Global Prostate Cancer - Hormonal Therapy Market (Million US$), 2011 - 2014
Figure 5-2: Global Prostate Cancer - Forecast for Hormonal Therapy Market (Million US$), 2015 - 2020
Figure 5-3: Global Prostate Cancer - Chemotherapy Market (Million US$), 2011 - 2014
Figure 5-4: Global Prostate Cancer - Forecast for Chemotherapy Market (Million US$), 2015 - 2020
Figure 5-5: Global Prostate Cancer - Immunotherapy Market (Million US$), 2011 - 2014
Figure 5-6: Global Prostate Cancer - Forecast for Immunotherapy Market (Million US$), 2015 - 2020
Figure 5-7: Global Prostate Cancer - Targeted Therapy Market (Million US$), 2013 - 2014
Figure 5-8: Global Prostate Cancer - Forecast for Targeted Therapy Market (Million US$), 2015 - 2020
Figure 6-1: Global - Zytiga Drugs Sales (Million US$), 2011 - 2014
Figure 6-2: Global - Forecast for Zytiga Drugs Sales (Million US$), 2015 - 2020
Figure 6-3: Global - Gonax/ Firmagon Drugs Sales (Million US$), 2012 - 2014
Figure 6-4: Global - Forecast for Gonax Drugs Sales (Million US$), 2015 - 2020
Figure 6-5: Global - Lupron Drugs Sales (Million US$), 2009 - 2014
Figure 6-6: Global - Forecast for Lupron Drugs Sales (Million US$), 2015 - 2020
Figure 6-7: Global - Zoladex Drugs Sales (Million US$), 2009 - 2014
Figure 6-8: Global - Forecast for Zoladex Drugs Sales (Million US$), 2015 - 2020
Figure 6-9: Global - Decapeptyl Drugs Sales (Million US$), 2009 - 2014
Figure 6-10: Global - Forecast for Decapeptyl Drugs Sales (Million US$), 2015 - 2020
Figure 6-11: Global - Eligard Drugs Sales (Million US$), 2009 - 2014
Figure 6-12: Global - Forecast for Eligard Drugs Sales (Million US$), 2015 - 2020
Figure 6-13: Global - Vantas Drugs Sales (Million US$), 2009 - 2014
Figure 6-14: Global - Forecast for Vantas Drugs Sales (Million US$), 2015 - 2020
Figure 6-15: Global - Leuplin Drugs Sales (Million US$), 2009 - 2014
Figure 6-16: Global - Forecast for Leuplin Drugs Sales (Million US$), 2015 - 2020
Figure 6-17: Global - Casodex Drugs Sales (Million US$), 2009 - 2014
Figure 6-18: Global - Forecast for Casodex Drugs Sales (Million US$), 2015 - 2020
Figure 6-19: Global - Xtandi or MDV3100 Drugs Sales (Million US$), 2012 - 2014
Figure 6-20: Global - Forecast for Xtandi or MDV3100 Drugs Sales (Million US$), 2015 - 2020
Figure 6-21: Global - Xtandi US or MDV3100 Drugs Sales (Million US$), 2012 - 2014
Figure 6-22: Global - Forecast for Xtandi US or MDV3100 Drugs Sales (Million US$), 2015 - 2020
Figure 7-1: Global - Taxotere Drugs Sales (Million US$), 2011 - 2014
Figure 7-2: Global - Forecast for Taxotere Drugs Sales (Million US$), 2015 - 2020
Figure 7-3: Global - Jevtana Drugs Sales (Million US$), 2010 - 2014
Figure 7-4: Global - Forecast for Jevtana Drugs Sales (Million US$), 2015 - 2020
Figure 8-1: Global - Provenge Drugs Sales (Million US$), 2011 - 2014
Figure 8-2: Global - Forecast for Provenge Drugs Sales (Million US$), 2015 - 2020
Figure 9-1: Global - Xofigo or Alpharadin Drugs Sales (Million US$), 2013 - 2014
Figure 9-2: Global - Forecast for Xofigo or Alpharadin Drugs Sales (Million US$), 2015 - 2020
Figure 11-1: Therapeutic Categories - Overall Success Rate from Phase 1 through Likelihood of Approval (Percent), 2004 - 2010


List of Tables

Table 4-1: Global - Prostate Cancer Therapy Market Share (Percent), 2011 - 2014
Table 4-2: Global - Forecast for Prostate Cancer Therapy Market Share (Percent), 2015 - 2020
Table 4-3: Global - Prostate Cancer Drugs Market Share (Percent), 2011 - 2014
Table 4-4: Global - Forecast for Prostate Cancer Drugs Market Share (Percent), 2015 - 2020